Skip to content

Comparison of Cicatrization Using Topic Light Emitted Diode in Patients Underwent to Abdominoplasty

Comparison Between the Application and No Application of Led (light emitted diode) in Cicatrization of Patient Underwent to Abdominoplasty

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-49pk78
Enrollment
Unknown
Registered
2016-05-17
Start date
2014-03-25
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cicatrix, keloid, regeneration, wound healing

Interventions

Experimental group: 27 patients selected for the inclusion criteria who underwent abdominal cosmetic surgery (abdominoplasty), whose scar on the right side was treated with topical therapy with Led (h
Procedure/surgery
Other

Sponsors

Pontifícia Universidade Católica do Rio Grande do Sul
Lead Sponsor
INSERM U1051 Institut des Neurosciences de Montpellier
Collaborator

Eligibility

Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: Patients with informed consent signed; caucasian; patients underwent abdominoplasty; patients in whose immediate postoperative period does not show signs of distress or mechanical trauma of the sutured tissue; BMI between 20-30 kg/m2

Exclusion criteria

Exclusion criteria: Patient with indication of multifunctional abdominoplasty or previously undergone to bariatric surgery; patients previously undergoing abdominal surgery that could compromise the vitality of the abdominal flap (cholecystectomy laparotomy for weapon or firearm trauma); patients with autoimmune disorders of collagen metabolism; smoking; diabetes mellitus; chronic hypertension; alcoholism; bleeding disorder; protein malnutrition; immunodeficiency; patients suffering acute or chronic dermatitis or using pharmacological treatment with corticosteroids or chemotherapy; patients undergoing radiation therapy for any reason in the abdominal-pelvic region; patients with known healing disorders (hypertrophic scars or keloids); patients with intestinal bad absorption; patients who have been conducting strict diet prior to surgery; patients who are using another type of product or drug for preventing or improving healing; patient presenting tattoo in the abdominal region and difficult the postoperative evaluation of the scar; patients with medical conditions that interfere with normal wound healing (vitamin C deficiency; iron deficiency; anemia)

Design outcomes

Primary

MeasureTime frame
Improved of cicatrization evaluated by Vancouver and Draajiers assessment scales the first, sixth and twelfth months postoperative observing the decrease of the score scales considering a variation of more than 5% of the observations pre and post intervention

Secondary

MeasureTime frame
Improved of cicatrization evaluated with preoperative biopsies, one, six and twelve months postoperative biopsies observing the collagen quantity and fibroblast migration considering a variation of more than 5% of the observations pre and post intervention;Improved of cicatrization evaluated by profilometry technique the first, sixth and twelfth months postoperative observing the decrease of the surface irregularities considering a variation of more than 5% of the observations pre and post intervention

Countries

Brazil

Contacts

Public Contactrenato franz ramos

Pontifícia Universidade Católica do Rio Grande do Sul

renatomatta82@hotmail.com+555133203000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)